Tagworks Pharmaceuticals

Focus: Tagworks Pharmaceuticals is a Netherlands-based biotech focused on antibody-drug conjugate (ADC) technology with initial pipeline activity in oncology and neurology. The company is in early clinical stage with minimal public commercial footprint.

Neurology

Profile data last refreshed 1h ago · AI intelligence enriched 2w ago

Open Jobs

About Tagworks Pharmaceuticals

AI assessmentNot Hiring

No open roles listed right now. Follow Tagworks Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

TGW101

Advanced Solid Tumors

Phase 1

Clinical Trials (1)

NCT06959706Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

Phase 1

Help build intelligence for Tagworks Pharmaceuticals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Specialized focus on ADCs, a high-growth modality with significant IP moat and increasing pharma investment
Ground-floor opportunity at an early-stage company with potential for significant equity upside if pipeline advances
European location (Nijmegen) offers access to strong academic research networks and lower cost-of-living than US biotech hubs

Watch Out For

Only 1 active job opening signals minimal hiring velocity and limited career trajectory or lateral movement options
No revenue, funding data, or financial disclosures available—cash runway and series stage unknown, creating material liquidity risk
Extremely early pipeline (2 Phase 1 programs only) with no Phase 2/3 catalysts on visible horizon limits near-term validation milestones

Generated by Claude from Tagworks Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

[111In]In-DOTA-TCO-trastuzumab

HER2 Positive Solid Tumor

Phase 1

Clinical Trials (1)

NCT07009184TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers.

Phase 1

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Top TAs: Oncology

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Oncology

2 pipeline

Marketed

Pipeline